13 March 2023 - - US-based Advanced Infusion Care, a division of AIS Healthcare, now offers GAMMAKED, developed by Kedrion for the treatment of patients with primary humoral immunodeficiency, idiopathic thrombocytopenic purpura in adults and children, and chronic inflammatory demyelinating polyneuropathy in adults, the company said.

The nationally accredited home infusion teams at AIC collaborate closely with physicians to provide specialized in-home infusion services.

This new therapy option, offered under a limited distribution contract with Kedrion, expands AIC's ability to serve immunoglobulin infusion patients.

GAMMAKED is indicated for the treatment of PI in patients 2 years of age or older, ITP in adults and children, and CIDP in adults.

Approved by the U.S Food and Drug Administration in 2011, the therapy is now available at all AIC locations (Valdosta, Georgia; Birmingham, Alabama; Clinton, Mississippi; Panama City, Florida; Dallas, Texas).

Like all AIC patients, those with PI, ITP, and CIDP will receive a high level of care from AIC, including 24/7 access to clinical and support staff.

Every patient is assigned a dedicated team of professionals, including clinical pharmacists, infusion nurse specialists, and intake managers to provide support throughout the treatment process.

For physicians, AIC is a full-service care delivery partner. We have contracts with multiple immunoglobulin suppliers, like Kedrion.

These contracts help us ensure prescribed therapies are always in stock. We also work directly with patients, insurance companies, and physician offices to secure all needed authorizations and complete paperwork.

AIS Healthcare is dually accredited by URAC and the Accreditation Commission for Health Care, further setting it apart from other infusion services providers.